The epigenetic state of the cell of origin defines mechanisms of leukemogenesis
Leukemia · 2025
DOI: 10.1038/s41375-024-02428-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia, 2025. Verfasst von Zhiheng Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Program and Stem Cell Transplantation Programs, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Leukemia, Myeloid, Acute, Hematopoietic Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, V Foundation for Cancer Research (V Foundation).
Abstract (Originalsprache)
Acute myeloid leukemia (AML) shows variable clinical outcome. The normal hematopoietic cell of origin impacts the clinical behavior of AML, with AML from hematopoietic stem cells (HSCs) prone to chemotherapy resistance in model systems. However, the mechanisms by which HSC programs are transmitted to AML are not known. Here, we introduce the leukemogenic MLL-AF9 translocation into defined human hematopoietic populations, finding that AML from HSCs is enriched for leukemic stem cells (LSCs) compared to AML from progenitors. By epigenetic profiling, we identify a putative inherited program from the normal HSC that collaborates with oncogene-driven programs to confer aggressive behavior in HSC-AML. We find that components of this program are required for HSC-AML growth and survival and identify RNA polymerase (RNAP) II-mediated transcription as a therapeutic vulnerability. Overall, we propose a mechanism as to how epigenetic programs from the leukemic cell of origin are inherited through transformation to impart the clinical heterogeneity of AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stem Cell Program and Stem Cell Transplantation Programs, Boston Children's Hospital, Boston, MA, USA.
- Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
- Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.
- Federal University of Santa Catarina, Florianopolis, Brazil.
- Massachusetts Institute of Technology, Cambridge, MA, USA.
- Howard Hughes Medical Institute, Boston, MA, USA.
ORCID-Profile: Sara Fierstein, Mayuri Tanaka-Yano, Katie Frenis, Marcelo Falchetti, Edroaldo Lummertz da Rocha, Shaoyan Hu, Qian Zhu, R Grant Rowe
Förderung
- NIDDK NIH HHS
- V Foundation for Cancer Research (V Foundation)
Zitieren
APA
Li, Z., Fierstein, S., Tanaka-Yano, M., Frenis, K., Chen, C. C., Wang, D., Falchetti, M., Côté, P., Curran, C., Lu, K., Liu, T., Orkin, S., Li, H., Lummertz da Rocha, E., Hu, S., Zhu, Q., & Rowe, R. G. (2025). The epigenetic state of the cell of origin defines mechanisms of leukemogenesis. Leukemia. https://doi.org/10.1038/s41375-024-02428-y
Vancouver
Li Z, Fierstein S, Tanaka-Yano M, Frenis K, Chen CC, Wang D, et al. The epigenetic state of the cell of origin defines mechanisms of leukemogenesis. Leukemia. 2025. doi:10.1038/s41375-024-02428-y
BibTeX
@article{Li2025,
author = {Li, Zhiheng and Fierstein, Sara and Tanaka-Yano, Mayuri and Frenis, Katie and Chen, Chun-Chin and Wang, Dahai and Falchetti, Marcelo and Côté, Parker and Curran, Christina and Lu, Kate and Liu, Tianxin and Orkin, Stuart and Li, Hojun and Lummertz da Rocha, Edroaldo and Hu, Shaoyan and Zhu, Qian and Rowe, R Grant},
title = {The epigenetic state of the cell of origin defines mechanisms of leukemogenesis},
journal = {Leukemia},
year = {2025},
doi = {10.1038/s41375-024-02428-y}
}
EUVIMED